1Smice DC,Prentice R,Thompson DJ,et al.Assiociation of exogenous estrogen and endometrial carcinoma[J].N Eng J Med,1975,293:1164-1167.
2Beresford SA,Weiss NS,Voigt LF,et al.Risk of endometrial cancer in Relation to use of estrogen combined with cyclic progestagen therapy in postmenopausal[J].Lancet,1997,349:458-461.
3Creasman WT,Henderson D,Hinshaw W,et al.Estrogen replacement therapy in the patient treated for endometrial cancer[J].Obstet Gynecol,1986,67:326-330.
4Lee RB,Burke TW,Park RC.Estrogen replacement therapy following treatment for stage Ⅰ endometrial cancer[J].Gynecol Oncol,1990,36:189-191.
5Chapman JA,DiSaia PJ,Osann K,et al.Estrogen replacement in surgical stage I and II endometrial cancer survivors[J].Am J Obstet Gynecol,1996,175(5):1195-200.
6Suriano KA,McHale M,McLaren CE,et al.Estrogen replacement therapy in endometrial cancer patients:a matched control study[J].Obstet Gynecol,2001,97(4):555-560.
7Schindler AE.Hormone replacement therapy (HRT) in women after genital cancer[J].Maturitas,2002,(Suppl 1):S105-S111.
8Morch LS,Lokkegaard E,Andreasen AH,et al.Hormone therapy and ovarian cancer[J].JAMA,2009,302:298-305.
9Beral V,Bull D,Green J,et al.Ovarian cancer and hormone replacement therapy in the Million Women Study[J].Lancet,2007,369(9574):1703-1710.
10Mascarenhas C,Lambe M,Bellocco,et al.Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival[J].Int J cancer,2006,119:2907-2915.
